Journal for ImmunoTherapy of Cancer (Nov 2021)
496 Toxicity of an Fc engineered anti-CD40 antibody is abrogated by intratumoral injection and results in durable anti-tumor immunity in patients
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)